Introduction

Expert Opin Drug Saf. 2016 Dec;15(sup1):1. doi: 10.1080/14740338.2016.1240784.
No abstract available

Keywords: Rheumatic diseases; anti-TNF agents; immunogenicity; safety.

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use
  • Drug Design
  • Humans
  • Rheumatic Diseases / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha